Article Information
History
- May 31, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Sukuma Saengduenchai, Ph.D.1,
- Sumnao Nilaban, Ph.D.1,
- Tanya Singtho, M.Sc.1,
- Apichart Ranuwattananon, M.D.1 and
- Rasmon Kalayasiri, M.D.2,3,*
- 1Princess Mother National Institute on Drug Abuse Treatment, Department of Medical Services, Ministry of Public Health, Pathumthani, Thailand
- 2Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
- 3Department of Psychiatry, King Chulalongkorn Memorial Hospital, Bangkok, Thailand
- ↵*Correspondence address
: Rasmon Kalayasiri, Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, 1873 Rama 4 Road, Pathumwan, Bangkok 10330, Thailand. Telephone number +66 2256 4000 Ext. 61559. Email address : rasmon.k{at}chula.ac.th
Posted May 31, 2022.
The Development of the Substance Use Disorder Screening Test (SUDST) according to the DSM-5
